Extended Depth-of-Field Intraocular Lenses: An Update.


Journal

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
ISSN: 2162-0989
Titre abrégé: Asia Pac J Ophthalmol (Phila)
Pays: China
ID NLM: 101583622

Informations de publication

Date de publication:
Historique:
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 10 4 2021
Statut: ppublish

Résumé

Extended depth-of-focus (EDOF) is a new intraocular lens (IOL) technology in the treatment of presbyopia. In contrast to multifocal (MF) IOLs, EDOF lenses create a single elongated focal point, rather than several foci, to enhance depth of focus. In this way, EDOF IOLs aim to reduce photic phenomena, glare, and halos, which have been reported in MF IOLs. A potential disadvantage is a decrease of retinal image quality if the amount of the aberrations is excessively increased. Frequently, EDOF IOLs are combined with MF optical designs; for this reason, EDOF IOLs are commonly a subject of confusion with optical multifocality concepts. The aim of this article is to clarify what an EDOF IOL is and to discuss the recently reported outcomes with these IOLs. We propose naming lenses that have combined optical designs as "hybrid IOLs."

Identifiants

pubmed: 32511121
doi: 10.1097/APO.0000000000000296
pii: 01599573-202006000-00005
pmc: PMC7299221
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-202

Références

J Vis. 2004 Apr 16;4(4):272-80
pubmed: 15134474
J Cataract Refract Surg. 2016 Sep;42(9):1268-1275
pubmed: 27697244
BMC Ophthalmol. 2019 Aug 28;19(1):197
pubmed: 31462225
Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):285-289
pubmed: 31397676
Klin Monbl Augenheilkd. 2019 Apr;236(4):384-390
pubmed: 30763956
J Refract Surg. 2015 Apr;31(4):230-5
pubmed: 25884577
Opt Express. 2010 Jan 18;18(2):1637-48
pubmed: 20173991
J Cataract Refract Surg. 2019 May;45(5):539-543
pubmed: 30770162
Eur J Ophthalmol. 2016 May-Jun;26(3):230-5
pubmed: 26350987
J Refract Surg. 2017 Mar 1;33(3):146-149
pubmed: 28264127
J Curr Ophthalmol. 2017 Jul 29;29(4):274-281
pubmed: 29270474
Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):273-274
pubmed: 31373910
BMJ Case Rep. 2019 Nov 10;12(11):
pubmed: 31712245
Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1091-1099
pubmed: 30824995
Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1387-97
pubmed: 26671689
Ophthalmology. 2017 Jan;124(1):139-141
pubmed: 27743644
J Cataract Refract Surg. 2019 Jun;45(6):798-802
pubmed: 30876785
J Refract Surg. 2020 Jan 1;36(1):12-19
pubmed: 31917846
Optom Vis Sci. 2012 Dec;89(12):1702-7
pubmed: 23190714
Eye (Lond). 2019 Jul;33(7):1096-1103
pubmed: 30792521
J Refract Surg. 2018 Sep 1;34(9):629-631
pubmed: 30199568
J Refract Surg. 2016 Jul 1;32(7):436-42
pubmed: 27400074
Indian J Ophthalmol. 2013 Nov;61(11):678-80
pubmed: 24145560
Am J Ophthalmol. 2015 Dec;160(6):1176-1184.e1
pubmed: 26299536
Indian J Ophthalmol. 2019 Jul;67(7):1200-1202
pubmed: 31238464
J Refract Surg. 2018 Apr 1;34(4):228-235
pubmed: 29634837
Taiwan J Ophthalmol. 2015 Apr-Jun;5(2):72-75
pubmed: 29018671
Asia Pac J Ophthalmol (Phila). 2017 Jul-Aug;6(4):339-349
pubmed: 28780781
Eye (Lond). 2019 Mar;33(3):404-410
pubmed: 30266985
J Refract Surg. 2017 Apr 1;33(4):257-265
pubmed: 28407166
J Cataract Refract Surg. 2016 Jan;42(1):138-47
pubmed: 26948789
Int Ophthalmol. 2017 Dec;37(6):1299-1304
pubmed: 27921205
Invest Ophthalmol Vis Sci. 1984 Dec;25(12):1458-60
pubmed: 6511231
J Cataract Refract Surg. 2019 Nov;45(11):1625-1636
pubmed: 31706517
Surv Ophthalmol. 2017 Sep - Oct;62(5):611-634
pubmed: 28366683

Auteurs

Piotr Kanclerz (P)

Hygeia Clinic, Gdańsk, Poland.

Francesca Toto (F)

Vissum Corporation, Alicante, Spain.

Andrzej Grzybowski (A)

Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland.
Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland.

Jorge L Alio (JL)

Vissum Corporation, Alicante, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH